MEDICAMEQ

Medicamen Biotech Share Price Medicamen Biotech

₹490.9
0.9 (0.18%)
03 March, 2024 12:04 BSE: 531146 NSE: MEDICAMEQISIN: INE646B01010

Start SIP in Medicamen Biotech

Start SIP

Medicamen Biotech Performance

Day Range

  • Low 485
  • High 507
₹ 490

52 Week Range

  • Low 470
  • High 845
₹ 490
  • Open Price507
  • Previous Close490
  • Volume5872

Medicamen Biotech Share Price

  • Over 1 Month -7.69%
  • Over 3 Month -22.39%
  • Over 6 Month -32.13%
  • Over 1 Year -24.12%

Medicamen Biotech Key Statistics

P/E Ratio 55.6
PEG Ratio -3.1
Market Cap Cr 624
Price to Book Ratio 3.3
EPS 11.9
Dividend 0.2
Relative Strength Index 37.47
Money Flow Index 51
MACD Signal -12.03
Average True Range 25.03
Medicamen Biotech Financials
IndicatorDec 2023Sep 2023Jun 2023Mar 2023
Oper Rev Qtr Cr 44434137
Operating Expenses Qtr Cr 39373330
Operating Profit Qtr Cr 6677
Depreciation Qtr Cr 2222
Interest Qtr Cr 1111
Tax Qtr Cr 1111
Net Profit Qtr Cr 3344
IndicatorMar 2023
Total Revenue Annual Cr 140
Operating Expenses Annual Cr 114
Operating Profit Annual in Cr 24
Depreciation Cr 6
Interest Annual Cr 3
Tax Annual Cr 2
Net Profit Annual Cr 15
IndicatorMar 2023
Cash from Operating Activity Annual Cr -3
Cash from Investing Activity Annual Cr -8
Cash from Financing Annual Activity Cr 28
Net Cash Flow Annual Cr 17
IndicatorMar 2023
Total ShareHolders Funds Annual Cr 193
Fixed Assets Annual Cr 92
Total Non Current Assets Annual Cr 119
Total Current Assets Annual Cr 158
Total Assets Annual Cr 277
IndicatorMar 2023
Book Value Per Share Annual Rs 152
ROE Annual % 8
ROCE Annual % 10
Total Debt to Total Equity Annual -
EBDIT Annual Margin % 19
IndicatorDec 2023Sep 2023Jun 2023Mar 2023
Oper Rev Qtr Cr 47444239
Operating Expenses Qtr Cr 42393532
Operating Profit Qtr Cr 5576
Depreciation Qtr Cr 2222
Interest Qtr Cr 1111
Tax Qtr Cr 1111
Net Profit Qtr Cr 2144
IndicatorMar 2023
Total Revenue Annual Cr 143
Operating Expenses Annual Cr 117
Operating Profit Annual in Cr 24
Depreciation Cr 6
Interest Annual Cr 3
Tax Annual Cr 2
Net Profit Annual Cr 15
IndicatorMar 2023
Cash from Operating Activity Annual Cr -6
Cash from Investing Activity Annual Cr -6
Cash from Financing Annual Activity Cr 29
Net Cash Flow Annual Cr 17
IndicatorMar 2023
Total ShareHolders Funds Annual Cr 191
Fixed Assets Annual Cr 93
Total Non Current Assets Annual Cr 115
Total Current Assets Annual Cr 163
Total Assets Annual Cr 279
IndicatorMar 2023
Book Value Per Share Annual Rs 151
ROE Annual % 8
ROCE Annual % 10
Total Debt to Total Equity Annual -
EBDIT Annual Margin % 19

Medicamen Biotech Technicals

EMA & SMA

Current Price
₹490.9
0.9 (0.18%)
pointer
  • Bullish Moving Average
  • ___
  • 0
  • Bearish Moving Average
  • ___
  • 16
  • 20 Day
  • ₹514.76
  • 50 Day
  • ₹541.90
  • 100 Day
  • ₹578.98
  • 200 Day
  • ₹628.85
  • 20 Day
  • ₹514.62
  • 50 Day
  • ₹544.20
  • 100 Day
  • ₹583.87
  • 200 Day
  • ₹648.88

Medicamen Biotech Resistance and Support

PIVOT
₹494.3
Resistance
First Resistance 503.60
Second Resistance 516.30
Third Resistance 525.60
RSI 37.47
MFI 51.00
MACD Single Line -12.03
MACD -14.50
Support
First Resistance 481.60
Second Resistance 472.30
Third Resistance 459.60

Medicamen Biotech Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 22,155 1,128,354 50.93
Week 21,628 1,350,681 62.45
1 Month 38,982 1,894,534 48.6
6 Month 27,512 1,376,700 50.04

Medicamen Biotech Result Highlights

Medicamen Biotech Synopsis

NSE-Medical-Generic Drugs

Medicamen Biotec is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company’s Total Operating Revenue is Rs. 137.88 Cr. and Equity Capital is Rs. 12.65 Cr. for the Year ended 31/03/2023. Medicamen Biotech Ltd. is a Public Limited Listed company incorporated on 22/12/1993 and has its registered office in the State of Delhi, India. Company’s Corporate Identification Number(CIN) is L74899DL1993PLC056594 and registration number is 056594.
Market Cap 623
Sales 165
Shares in Float 0.72
No of funds 6
Yield 0.2
Book Value 3.22
U/D Vol ratio 1.5
LTDebt / Equity 3
Alpha -0.24
Beta 1.08

Medicamen Biotech

Owner NameDec-23Sep-23Jun-23Mar-23
Promoters 43.21%43.21%43.21%43.21%
Mutual Funds
Foreign Portfolio Investors 0.22%0.22%0.16%0.19%
Individual Investors 31.9%31.81%31.43%31.49%
Others 24.67%24.76%25.2%25.11%

Medicamen Biotech Management

Name Designation
Mr. Rahul Bishnoi Chairman
Dr. Vimal Kumar Shrawat Non Executive Director
Mr. Sanjay Bansal Non Executive Director
Mr. Suresh Kumar Singh Non Executive Director
Mr. Ashwani Kumar Sharma Non Executive Director
Mr. Harish Pande Independent Director
Ms. Sangeeta Bishnoi Independent Director
Dr. Ravi Kumar Bansal Independent Director
Mr. Arun Kumar Independent Director
Ms. Sumita Dwivedi Independent Director

Medicamen Biotech Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Medicamen Biotech Corporate Action

Date Purpose Remarks
2024-02-12 Quarterly Results
2023-11-10 Quarterly Results
2023-08-08 Quarterly Results
2023-05-29 Audited Results & Final Dividend
2023-02-10 Quarterly Results

Medicamen Biotech MF Shareholding

Name Amount(cr)

Medicamen Biotech FAQs

What is Share Price of Medicamen Biotech ?

Medicamen Biotech share price is ₹490 As on 03 March, 2024 | 11:50

What is the Market Cap of Medicamen Biotech ?

The Market Cap of Medicamen Biotech is ₹624.2 Cr As on 03 March, 2024 | 11:50

What is the P/E ratio of Medicamen Biotech ?

The P/E ratio of Medicamen Biotech is 55.6 As on 03 March, 2024 | 11:50

What is the PB ratio of Medicamen Biotech ?

The PB ratio of Medicamen Biotech is 3.3 As on 03 March, 2024 | 11:50

Q2FY23